clinthe Profile Banner
Clinical Therapeutics Profile
Clinical Therapeutics

@clinthe

Followers
1K
Following
126
Media
947
Statuses
8K

The International Peer-Reviewed Journal of Drug Therapy Supports Open Access Opinions are the editorial team’s.

Philadelphia, US & Oxford, UK
Joined September 2011
Don't wanna be here? Send us removal request.
@clinthe
Clinical Therapeutics
1 year
Check out our July issue here!.
0
0
1
@clinthe
Clinical Therapeutics
2 years
RT @TheLancet: Risk of dying from cancer in some poorer districts of England over 70% higher than wealthy districts, a new study in @TheLan….
0
287
0
@clinthe
Clinical Therapeutics
2 years
Join us in exploring the latest in Atherosclerotic Vascular Disease! .Entire collection: #Cardiology #VascularHealth #Atherosclerosis #MedicalResearch #HealthcareInnovation #AIinMedicine #CardiovascularDisease.
0
0
0
@clinthe
Clinical Therapeutics
2 years
ASCVD is a major health challenge, surpassing other conditions in disability and mortality. This update explores trends, AI applications, peripheral and cerebrovascular disease, atherosclerosis biology, inflammation, therapies, lipid-lowering optimization, and nanomedicines.
1
0
0
@clinthe
Clinical Therapeutics
2 years
Specialty Update: Atherosclerotic Vascular Disease.πŸ” Our November issue, curated by Guest Editors Peter L. Thompson and Juliana Hamzah, dives deep into Atherosclerotic Vascular Disease (ASCVD) with 12 insightful articles. πŸ“° Guest Editorial:
1
1
0
@clinthe
Clinical Therapeutics
2 years
Join us in exploring innovative approaches to enhance the well-being of older adults. Stay tuned for more insights and advancements in geriatric care. #HealthcareInnovation #MedicalAdvancements.
0
0
0
@clinthe
Clinical Therapeutics
2 years
4/ How to Deprescribe Potentially Inappropriate Medications During the Hospital-to-Home Transition: Stakeholder Perspectives on Essential Tasks by Jinjiao Wang et al. Read Original Research: #Deprescribing #PatientSafety.
1
0
0
@clinthe
Clinical Therapeutics
2 years
3/ Optimizing Hypertension Treatment in Older Patients Through Home Blood Pressure Monitoring Pharmacists in Primary Care: The MINOR Clinical Trial by Pablo Maciel Moreira et al. Read Original Research: #Hypertension #MedicationOptimization.
1
0
0
@clinthe
Clinical Therapeutics
2 years
2/ Telepharmacy Model of Care by Christine Cigolle et al. Assessing the feasibility of a medication review and deprescribing model in older adults, using telemedicine and pharmacy technicians. Read Pilot Study: #Telepharmacy #Deprescribing.
1
0
0
@clinthe
Clinical Therapeutics
2 years
1/ Informatics Tools in Deprescribing by Shira G. Winter et al. Explore the development and dissemination of the VIONE Methodology in a High Reliability Organization. Read Commentary: #Deprescribing #MedicationOptimization.
1
0
0
@clinthe
Clinical Therapeutics
2 years
Our October Specialty Update, curated by Geriatrics Topic Editor, William W. Hung, shines a spotlight on the crucial theme of Deprescribing in Older Adults. #Geriatrics #Deprescribing #MedicalResearch.
1
0
0
@clinthe
Clinical Therapeutics
2 years
Read the full update for a comprehensive view of the latest advancements and challenges in the field:Β . #PsoriaticArthritisAwareness #Rheumatology #MedicalResearch #Healthcare #PsAResearch #PatientCare.
0
0
0
@clinthe
Clinical Therapeutics
2 years
8/8 Challenges in Managing PsA in Latin America.Primary challenges in managing Psoriatic Arthritis in Latin America, with a focus on socioeconomic factors. πŸ‘‰
1
0
0
@clinthe
Clinical Therapeutics
2 years
7/8 Enthesitis in Spondyloarthritis and PsA: Corticosteroid Injections .This study explores the use of corticosteroid injections in treating entheseal manifestations in PsA and spondyloarthritis. πŸ‘‰
1
0
0
@clinthe
Clinical Therapeutics
2 years
6/8 Lifestyle Modifications and Nonpharmacologic Interventions.A systematic review, focusing on the potential benefits of lifestyle modifications and nonpharmacologic interventions for PsA patients. πŸ‘‰
1
0
0
@clinthe
Clinical Therapeutics
2 years
5/8 Pharmacologic Treatment Strategies .This study provides current insights into PsA therapeutic strategies, focusing on disease domains and related conditions. πŸ‘‰
1
0
0
@clinthe
Clinical Therapeutics
2 years
4/8 Comorbidities in PsA .This narrative review explores common comorbidities and extra-articular manifestations in PsA. πŸ‘‰
1
0
0
@clinthe
Clinical Therapeutics
2 years
3/8 Musculoskeletal Ultrasonography.A survey investigating its utilization and availability in PsA management among members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). πŸ‘‰
1
0
0
@clinthe
Clinical Therapeutics
2 years
2/8 Musculoskeletal Ultrasonography.This study delves into the rising popularity of musculoskeletal ultrasound and its utility in PsA research and practice. πŸ‘‰
1
0
0
@clinthe
Clinical Therapeutics
2 years
1/8 Genetic Studies on PsA Susceptibility.This narrative review explores genetic risk factors distinguishing PsA from cutaneous psoriasis. πŸ‘‰
1
0
0